title: Recent developments in the treatment of anxiety disorders in children and adolescents.
abstract: Anxiety disorders are among the most common emotional difficulties experienced by children and young people. They cause significant disturbance to the lives of young people and their families and present a risk for lifelong psychological disturbance. Effective psychological (ie, cognitive-behaviour therapy (CBT)) and pharmacological interventions (eg, selective serotonin reuptake inhibitors (SSRIs)) have been established. However, the risk of adverse effects and unknown long-term effects of using SSRIs has led to recommendations that CBT is delivered as a first-line intervention. Recent innovations have included the development of low-intensity CBT programmes, delivered briefly via parents or online. These hold promise to increase access to psychological therapies for children and young people with these common and severe difficulties.
authors.affiliation: School of Psychology and Clinical Language Sciences, University of Reading, Reading, Berkshire, UK.
authors.forename: Cathy
authors.initials: C
authors.lastname: Creswell
authors.affiliation: School of Psychology and Clinical Language Sciences, University of Reading, Reading, Berkshire, UK.
authors.forename: Polly
authors.initials: P
authors.lastname: Waite
mesh_terms: D000293:Adolescent; D001008:Anxiety Disorders / Q000188:drug therapy / Q000523:psychology / Q000628:therapy*; D002648:Child; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D019317:Evidence-Based Medicine; D006801:Humans; D010290:Parents; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors